{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:14:43Z","timestamp":1785269683858,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.clineuro.2021.107092","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T20:14:29Z","timestamp":1639599269000},"page":"107092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Hyperammonemia during treatment with valproate in critically ill patients"],"prefix":"10.1016","volume":"212","author":[{"given":"Chiara","family":"De Fazio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Goffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Ferlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Orinckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savino","family":"Spadaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Brasseur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Gaspard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Antonucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Khattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Peluso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immacolata","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Creteur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Legros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Silvio","family":"Taccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2021.107092_bib1","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1378\/chest.06-2940","article-title":"Hyperammonemia in the ICU","volume":"132","author":"Clay","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.clineuro.2021.107092_bib2","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jhep.2015.01.009","article-title":"Hyperammonemia in ICU patients: a frequent finding associated with high mortality","volume":"62","author":"Prado","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.clineuro.2021.107092_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00467-011-1838-5","article-title":"Hyperammonemia in review: pathophysiology, diagnosis, and treatment","volume":"27","author":"Auron","year":"2012","journal-title":"Pedia Nephrol."},{"issue":"10231","key":"10.1016\/j.clineuro.2021.107092_bib4","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","article-title":"Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial","volume":"395","author":"Chamberlain","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2021.107092_bib5","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1185\/03007995.2012.694362","article-title":"Valproate-induced hyperammonemic encephalopathy: a brief review","volume":"28","author":"Lewis","year":"2012","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.clineuro.2021.107092_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/15563650902752376","article-title":"Carnitine in the treatment of valproic acid-induced toxicity","volume":"47","author":"Lheureux","year":"2009","journal-title":"Clin. Toxicol."},{"issue":"22","key":"10.1016\/j.clineuro.2021.107092_bib7","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1056\/NEJMe078075","article-title":"Alternative-pathway therapy for hyperammonemia","volume":"356","author":"Shih","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.clineuro.2021.107092_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.eplepsyres.2012.04.001","article-title":"Risk factors for hyperammonemia associated with valproic acid therapy in adult epilepsy patients","volume":"101","author":"Yamamoto","year":"2012","journal-title":"Epilepsy Res."},{"issue":"11","key":"10.1016\/j.clineuro.2021.107092_bib9","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000066","article-title":"Risk factors of hyperammonemia in watients with epilepsy under valproic acid therapy","volume":"93","author":"Tseng","year":"2014","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.clineuro.2021.107092_bib10","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4103\/1817-1745.123697","article-title":"Unusual cause of hyperammonemia in two cases with short-term and long-term valproate therapy successfully treated by single dose carglumic acid","volume":"8","author":"Kasapkara","year":"2013","journal-title":"J. Pedia Neurosci."},{"key":"10.1016\/j.clineuro.2021.107092_bib11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jhep.2010.11.031","article-title":"New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA","volume":"55","author":"Aires","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.clineuro.2021.107092_bib12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJM198003203021204","article-title":"Valproic acid","volume":"302","author":"Browne","year":"1980","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2021.107092_bib13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1081\/CLT-120014645","article-title":"Valproic acid toxicity: overview and management","volume":"40","author":"Sztajnkrycer","year":"2002","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.clineuro.2021.107092_bib14","article-title":"Science review: carnitine in the treatment of valproic acid-induced toxicity \u2013 what is the evidence?","volume":"9","author":"Lheureux","year":"2005","journal-title":"Crit. Care"},{"key":"10.1016\/j.clineuro.2021.107092_bib15","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMra1600561","article-title":"Hepatic encephalopathy","volume":"375","author":"Wijdicks","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2021.107092_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2920108","article-title":"Carnitine and\/or acetylcarnitine deficiency as a cause of higher levels of ammonia","volume":"2016","author":"Maldonado","year":"2016","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.clineuro.2021.107092_bib17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/A:1021918104127","article-title":"Valproate-induced hyperammonemic encephalopathy","volume":"17","author":"Verrotti","year":"2002","journal-title":"Metab. Brain Dis."},{"issue":"8","key":"10.1016\/j.clineuro.2021.107092_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF00314255","article-title":"Pharmacokinetics of free and total sodium valproate in adolescents and young adults during maintenance therapy","volume":"235","author":"Herngren","year":"1988","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2021.107092_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.seizure.2018.04.012","article-title":"Determinants of free serum valproate concentration: a prospective study in patients on divalproex sodium monotherapy","volume":"59","author":"Nasreddine","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.clineuro.2021.107092_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.clinbiochem.2011.12.015","article-title":"Is blood ammonia influenced by kidney function? A prospective study","volume":"45","author":"Imran","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clineuro.2021.107092_bib21","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1172\/JCI109771","article-title":"Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency","volume":"65","author":"Tizianello","year":"1980","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.clineuro.2021.107092_bib22","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/MEJ.0b013e32832c7b18","article-title":"Severe valproic acid intoxication: case study on the unbound fraction and the applicability of extracorporeal elimination","volume":"16","author":"Van den Broek","year":"2009","journal-title":"Eur. J. Emerg. Med."},{"key":"10.1016\/j.clineuro.2021.107092_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-0404.2006.00793.x","article-title":"Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy","volume":"116","author":"Velioglu","year":"2007","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.clineuro.2021.107092_bib24","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1528-1157.2000.tb00263.x","article-title":"Valproic acid-induced hyperammonemic encephalopathy with triphasic waves","volume":"41","author":"Kifune","year":"2000","journal-title":"Epilepsia"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846721006211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846721006211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:40:29Z","timestamp":1759588829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846721006211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":24,"alternative-id":["S0303846721006211"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2021.107092","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperammonemia during treatment with valproate in critically ill patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2021.107092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107092"}}